Ondrej Volny1, Charlotte Zerna2, Ales Tomek1, Michal Bar1, Miloslav Rocek1, Radek Padr1, Filip Cihlar1, Miroslava Nevsimalova1, Lubomir Jurak1, Roman Havlicek1, Martin Kovar1, Petr Sevcik1, Vladimir Rohan1, Jan Fiksa1, David Cernik1, Rene Jura1, Daniel Vaclavik1, Petra Cimflova1, Josep Puig1, Dar Dowlatshahi1, Alexander V Khaw1, Enrico Fainardi1, Mohamed Najm1, Andrew M Demchuk1, Bijoy K Menon1, Robert Mikulik1, Michael D Hill1. 1. From the Department of Clinical Neurosciences, Calgary Stroke Program (O.V., C.Z., M.N., A.M.D., B.K.M., M.D.H.), and Department of Community Health Sciences (C.Z., B.K.M., M.D.H.), Cumming School of Medicine, University of Calgary, Canada; International Clinical Research Centre, Stroke Research Program & Department of Neurology (O.V., P.C., R.M.), and Department of Medical Imaging (P.C.), St. Anne's University Hospital; Faculty of Medicine (O.V., P.C., R.M.), Masaryk University, Brno; Department of Neurology (O.V.), Faculty Hospital Ostrava; 2nd Medical Faculty (A.T.) and First Faculty of Medicine and General University Hospital (J.F.), Department of Neurology, Charles University, Prague; Department of Neurology, Faculty of Medicine (M.B.), University Hospital Ostrava, University Ostrava; Department of Radiology, 2nd Faculty of Medicine (M.R., R.P.), Charles University in Prague and Motol University Hospital; Department of Radiology (F.C.) and Department of Neurology-Comprehensive Stroke Center (D.C.), Masaryk Hospital, Usti nad Labem; Department of Neurology (M.N.), Hospital Ceske Budejovice; Neurocenter (L.J.), Regional Hospital Liberec; Department of Neurology (R.H.), Military University Hospital, Prague; Department of Neurology (M.K.), Na Homolce Hospital, Prague; Department of Neurology, Faculty of Medicine in Pilsen (P.S., V.R.), Charles University in Prague, Pilsen; Department of Neurology (R.J.), University Hospital Brno and Faculty of Medicine Masaryk University; Department of Neurology (D.V.), AGEL Research and Training Institute, Ostrava Vitkovice Hospital, Czech Republic; Institute of Diagnostic Imaging (IDI)-Research Unit (IDIR) (J.P.), Parc Sanitari Pere Virgili, Barcelona; Girona Biomedical Research Institute (IDIBGI)-Medical Imaging (J.P.), Hospital Universitari de Girona Dr. Josep Trueta, Girona, Spain; Department of Clinical Neurosciences (D.P.), University of Western Ontario; Lawson Health Research Institute and Robarts Research Institute (A.V.K.), London, Canada; and Department of Experimental and Clinical Biomedical Sciences "Mario Serio" (E.F.), University of Florence, Italy. 2. From the Department of Clinical Neurosciences, Calgary Stroke Program (O.V., C.Z., M.N., A.M.D., B.K.M., M.D.H.), and Department of Community Health Sciences (C.Z., B.K.M., M.D.H.), Cumming School of Medicine, University of Calgary, Canada; International Clinical Research Centre, Stroke Research Program & Department of Neurology (O.V., P.C., R.M.), and Department of Medical Imaging (P.C.), St. Anne's University Hospital; Faculty of Medicine (O.V., P.C., R.M.), Masaryk University, Brno; Department of Neurology (O.V.), Faculty Hospital Ostrava; 2nd Medical Faculty (A.T.) and First Faculty of Medicine and General University Hospital (J.F.), Department of Neurology, Charles University, Prague; Department of Neurology, Faculty of Medicine (M.B.), University Hospital Ostrava, University Ostrava; Department of Radiology, 2nd Faculty of Medicine (M.R., R.P.), Charles University in Prague and Motol University Hospital; Department of Radiology (F.C.) and Department of Neurology-Comprehensive Stroke Center (D.C.), Masaryk Hospital, Usti nad Labem; Department of Neurology (M.N.), Hospital Ceske Budejovice; Neurocenter (L.J.), Regional Hospital Liberec; Department of Neurology (R.H.), Military University Hospital, Prague; Department of Neurology (M.K.), Na Homolce Hospital, Prague; Department of Neurology, Faculty of Medicine in Pilsen (P.S., V.R.), Charles University in Prague, Pilsen; Department of Neurology (R.J.), University Hospital Brno and Faculty of Medicine Masaryk University; Department of Neurology (D.V.), AGEL Research and Training Institute, Ostrava Vitkovice Hospital, Czech Republic; Institute of Diagnostic Imaging (IDI)-Research Unit (IDIR) (J.P.), Parc Sanitari Pere Virgili, Barcelona; Girona Biomedical Research Institute (IDIBGI)-Medical Imaging (J.P.), Hospital Universitari de Girona Dr. Josep Trueta, Girona, Spain; Department of Clinical Neurosciences (D.P.), University of Western Ontario; Lawson Health Research Institute and Robarts Research Institute (A.V.K.), London, Canada; and Department of Experimental and Clinical Biomedical Sciences "Mario Serio" (E.F.), University of Florence, Italy. charlotte.zerna@ucalgary.ca.
Abstract
OBJECTIVE: To undertake an effectiveness and safety analysis of EVT in patients with LVO and NIH Stroke Scale (NIHSS) score ≤6 using datasets of multicenter and multinational nature. METHODS: We pooled patients with anterior circulation occlusion from 3 prospective international cohorts. Patients were eligible if presentation occurred within 12 hours from last known well and baseline NIHSS ≤6. Primary outcome was modified Rankin Scale (mRS) score 0-1 at 90 days. Secondary outcomes included neurologic deterioration at 24 hours (change in NIHSS of ≥2 points), mRS 0-2 at 90 days, and 90-day all-cause mortality. We used propensity score matching to adjust for nonrandomized treatment allocation. RESULTS: Among 236 patients who fit inclusion criteria, 139 received EVT and 97 received medical management. Compared to medical management, the EVT group was younger (65 vs 72 years; p < 0.001), had more proximal occlusions (p < 0.001), and less frequently received concurrent IV thrombolysis (57.7% vs 71.2%; p = 0.04). After propensity score matching, clinical outcomes between the 2 groups were not significantly different. EVT patients had an 8.6% (95% confidence interval [CI] -8.8% to 26.1%) higher rate of excellent 90-day outcome, despite a 22.3% (95% CI, 3.0%-41.6%) higher risk of neurologic deterioration at 24 hours. CONCLUSIONS: EVT for LVO in patients with low NIHSS score was associated with increased risk of neurologic deterioration at 24 hours. However, both EVT and medical management resulted in similar proportions of excellent clinical outcomes at 90 days. CLASSIFICATION OF EVIDENCE: This study provides Class III evidence that for patients with acute anterior circulation ischemic strokes and LVO with NIHSS < 6, EVT and medical management result in similar outcomes at 90 days.
OBJECTIVE: To undertake an effectiveness and safety analysis of EVT in patients with LVO and NIH Stroke Scale (NIHSS) score ≤6 using datasets of multicenter and multinational nature. METHODS: We pooled patients with anterior circulation occlusion from 3 prospective international cohorts. Patients were eligible if presentation occurred within 12 hours from last known well and baseline NIHSS ≤6. Primary outcome was modified Rankin Scale (mRS) score 0-1 at 90 days. Secondary outcomes included neurologic deterioration at 24 hours (change in NIHSS of ≥2 points), mRS 0-2 at 90 days, and 90-day all-cause mortality. We used propensity score matching to adjust for nonrandomized treatment allocation. RESULTS: Among 236 patients who fit inclusion criteria, 139 received EVT and 97 received medical management. Compared to medical management, the EVT group was younger (65 vs 72 years; p < 0.001), had more proximal occlusions (p < 0.001), and less frequently received concurrent IV thrombolysis (57.7% vs 71.2%; p = 0.04). After propensity score matching, clinical outcomes between the 2 groups were not significantly different. EVT patients had an 8.6% (95% confidence interval [CI] -8.8% to 26.1%) higher rate of excellent 90-day outcome, despite a 22.3% (95% CI, 3.0%-41.6%) higher risk of neurologic deterioration at 24 hours. CONCLUSIONS: EVT for LVO in patients with low NIHSS score was associated with increased risk of neurologic deterioration at 24 hours. However, both EVT and medical management resulted in similar proportions of excellent clinical outcomes at 90 days. CLASSIFICATION OF EVIDENCE: This study provides Class III evidence that for patients with acute anterior circulation ischemic strokes and LVO with NIHSS < 6, EVT and medical management result in similar outcomes at 90 days.
Authors: Ondrej Volny; Antonin Krajina; Silvie Belaskova; Michal Bar; Petra Cimflova; Roman Herzig; Daniel Sanak; Ales Tomek; Martin Köcher; Miloslav Rocek; Radek Padr; Filip Cihlar; Miroslava Nevsimalova; Lubomir Jurak; Roman Havlicek; Martin Kovar; Petr Sevcik; Vladimir Rohan; Jan Fiksa; Bijoy K Menon; Robert Mikulik Journal: J Neurointerv Surg Date: 2017-11-16 Impact factor: 5.836
Authors: Eric E Smith; Gregg C Fonarow; Mathew J Reeves; Margueritte Cox; Daiwai M Olson; Adrian F Hernandez; Lee H Schwamm Journal: Stroke Date: 2011-09-08 Impact factor: 7.914
Authors: V Rajajee; C Kidwell; S Starkman; B Ovbiagele; J R Alger; P Villablanca; F Vinuela; G Duckwiler; R Jahan; A Fredieu; S Suzuki; J L Saver Journal: Neurology Date: 2006-09-26 Impact factor: 9.910
Authors: Melinda J Davis; Bijoy K Menon; Leyla B Baghirzada; Cynthia R Campos-Herrera; Mayank Goyal; Michael D Hill; David P Archer Journal: Anesthesiology Date: 2012-02 Impact factor: 7.892
Authors: Simon Nagel; Mehdi Bouslama; Lars U Krause; Clemens Küpper; Mirko Messer; Martina Petersen; Stephan Lowens; Moritz Herzberg; Peter A Ringleb; Markus A Möhlenbruch; Steffen Tiedt; Fabricio O Lima; Diogo C Haussen; Wade S Smith; Michael H Lev; Raul G Nogueira Journal: Stroke Date: 2018-10 Impact factor: 7.914
Authors: Amrou Sarraj; Ameer Hassan; Sean I Savitz; James C Grotta; Chunyan Cai; Kaushik N Parsha; Christine M Farrell; Bita Imam; Clark W Sitton; Sujan T Reddy; Haris Kamal; Nitin Goyal; Lucas Elijovich; Katelin Reishus; Rashi Krishnan; Navdeep Sangha; Abel Wu; Renata Costa; Ruqayyah Malik; Osman Mir; Rashedul Hasan; Lindsay M Snodgrass; Manuel Requena; Dion Graybeal; Michael Abraham; Michael Chen; Louise D McCullough; Marc Ribo Journal: Stroke Date: 2018-10 Impact factor: 7.914
Authors: Mirjam R Heldner; Christoph Zubler; Heinrich P Mattle; Gerhard Schroth; Anja Weck; Marie-Luise Mono; Jan Gralla; Simon Jung; Marwan El-Koussy; Rudolf Lüdi; Xin Yan; Marcel Arnold; Christoph Ozdoba; Pasquale Mordasini; Urs Fischer Journal: Stroke Date: 2013-03-07 Impact factor: 7.914
Authors: S M Mishra; J Dykeman; T T Sajobi; A Trivedi; M Almekhlafi; S I Sohn; S Bal; E Qazi; A Calleja; M Eesa; M Goyal; A M Demchuk; B K Menon Journal: AJNR Am J Neuroradiol Date: 2014-07-24 Impact factor: 3.825
Authors: Diogo C Haussen; Fabricio O Lima; Mehdi Bouslama; Jonathan A Grossberg; Gisele S Silva; Michael H Lev; Karen Furie; Walter Koroshetz; Michael R Frankel; Raul G Nogueira Journal: J Neurointerv Surg Date: 2017-08-02 Impact factor: 5.836
Authors: Robert W Regenhardt; Amine Awad; Andrew W Kraft; Joseph A Rosenthal; Adam A Dmytriw; Justin E Vranic; Anna K Bonkhoff; Martin Bretzner; Mark R Etherton; Joshua A Hirsch; James D Rabinov; Aneesh B Singhal; Natalia S Rost; Christopher J Stapleton; Thabele M Leslie-Mazwi; Aman B Patel Journal: Stroke Vasc Interv Neurol Date: 2022-05-20
Authors: Andrea Maria Alexandre; Iacopo Valente; Alessandro Pedicelli; Angelo Maria Pezzullo; Francesca Colò; Luca Scarcia; Andrea Romi; Mariangela Piano; Antonio Macera; Joseph Domenico Gabrieli; Giacomo Cester; Antonio Armando Caragliano; Sergio Lucio Vinci; Maria Ruggiero; Christian Commodaro; Andrea Saletti; Guido Andrea Lazzarotti; Mirco Cosottini; Valerio Da Ros; Luigi Bellini; Emilio Lozupone; Adriana Paladini; Valerio Brunetti; Roberta Morosetti; Giovanni Frisullo; Paolo Calabresi; Giacomo Della Marca; Aldobrando Broccolini Journal: Neurol Sci Date: 2021-11-29 Impact factor: 3.830